Abstract
Parkinson's disease (PD) is a common condition that, in the majority of cases, is idiopathic in origin. The loss of central dopaminergic pathways is well-known and in this paper a theory is presented that this is brought about by an autoimmune process. The lack of any HLA association or familial clumping for the disease does not exclude such a theory, as a common etiological agent may exist that we do not yet recognize, e.g., infection, or drugs. Several autoantibodies and disturbances in T-cell function have been found in PD. The theory proposes that the production of autoantibodies and T-cell activation are important in the pathogenesis of idiopathic PD by an action on the substance P striatonigral pathway and its input to the dopaminergic nigrostriatal pathway. The autoimmune destruction of the substance P input leads to a secondary loss of the dopaminergic system and hence PD.
References
Jan 1, 1978·Neuropharmacology·S Narumi, T Fujita
Jun 1, 1985·Neuropeptides·R Quirion, T V Dam
Mar 6, 1986·Nature·D Sun, H Wekerle
Jan 1, 1986·Clinical Neuropharmacology·R C Duvoisin
Jun 7, 1986·Journal of Theoretical Biology·R Barker
Mar 14, 1985·The New England Journal of Medicine·D C Gajdusek
Nov 20, 1986·Nature·J G GuilletM L Gefter
Jul 1, 1985·Journal of the Neurological Sciences·R J MarttilaU K Rinne
Feb 1, 1986·Acta Physiologica Scandinavica·A McRae DegueurceA Dahlström
Apr 1, 1986·Annals of Neurology·R C Duvoisin
Jan 1, 1985·Annals of Neurology·A K Lefvert, H Link
Dec 20, 1984·Nature·H NawaS Nakanishi
Nov 24, 1984·British Medical Journal·A Williams
Citations
Jan 1, 1993·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·R VolpiV Coiro
Oct 12, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Jessica A Hutter SaundersHoward E Gendelman
Oct 1, 1995·Journal of the Neurological Sciences·S ChibaM Kashiwagi
Nov 1, 1995·Journal of the Neurological Sciences·H KlüterH Kirchner
Jan 1, 1990·The International Journal of Neuroscience·R Sandyk
Oct 1, 1989·The International Journal of Neuroscience·R Sandyk
Oct 1, 1991·Neuropeptides·R Barker
Nov 5, 2016·Cell Research·Rosalind F Roberts, Edward A Fon
Feb 17, 2017·Parkinsonism & Related Disorders·Arun Parashar, Malairaman Udayabanu
Apr 3, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Bart P C van de WarrenburgNiall P Quinn
Feb 24, 2019·Reviews in the Neurosciences·Ava NasrolahiJavad Mahmoudi
Jul 1, 1996·Reviews in the Neurosciences·R Barker
Apr 1, 1993·Reviews in the Neurosciences·R Barker, S Dunnett
Jun 4, 2016·PloS One·Ignacio Riquelme Medina, Zelmina Lubovac-Pilav
Jun 1, 2011·Molecular Diagnosis & Therapy·Carmen NoelkerRichard Dodel
Feb 25, 2020·Oxidative Medicine and Cellular Longevity·Ovidiu-Dumitru IlieIoannis Mavroudis
Oct 22, 1998·Neurology·A HeinzD R Weinberger